Your browser doesn't support javascript.
loading
BRCA2 Polymorphisms and Breast Cancer Susceptibility: a Multi-Tools Bioinformatics Approach.
Jan, Haris; Khan, Najeeb Ullah; Al-Qaaneh, Ayman M; Tasleem, Munazzah; Almutairi, Mikhlid H; Ali, Ijaz.
Affiliation
  • Jan H; Institute of Biotechnology & Genetic Engineering (Health Division), The University of Agriculture Peshawar, Pakistan.
  • Khan NU; Institute of Biotechnology & Genetic Engineering (Health Division), The University of Agriculture Peshawar, Pakistan, najeebkhan@aup.edu.pk.
  • Al-Qaaneh AM; Department of Allied Health Sciences, Faculty of Nursing, Al-Balqa Applied University (BAU), Al-Salt 19117, Jordan.
  • Tasleem M; Department of Biochemistry, Jamia Hamdard, Delhi, India.
  • Almutairi MH; Zoology Department, College of Science, King Saud University, P.O. Box: 2455, 11451, Riyadh, Saudi Arabia.
  • Ali I; Centre for Applied Mathematics and Bioinformatics (CAMB), Gulf University for Science and Technology, Hawally, Kuwait.
Cell Physiol Biochem ; 58(2): 128-143, 2024 Mar 24.
Article de En | MEDLINE | ID: mdl-38623065
ABSTRACT
BACKGROUND/

AIMS:

The main focus of this investigation is to identify deleterious single nucleotide polymorphisms (SNPs) located in the BRCA2 gene through in silico approach, thereby,providing an understanding of potential consequences regarding the susceptibility to breast cancer.

METHODS:

The GenomAD database was used to identify SNPs. To determine the potential adverse consequences, our study employed various prediction tools, including SIFT, PolyPhen, PredictSNP, SNAP2, PhD-SNP, and ClinVar. The pathogenicity associated with the deleterious snSNPs was evaluated bu MutPred and Fathmm. Additionally, I-Mutant and MuPro were used to assess the stability, followed by conservation and protein-protein interaction analysis using robust computational tools. The 3D structure of BRCA2 protein was generated by SwissModel, followed by validation using PROCHECK and Errat.

RESULTS:

The GenomAD database was used to identify a total of 7, 921 SNPs, including 1940 missense SNPs. A set of 69 SNPs predicted by consensus to be damaging across all platforms was identified. Mutpred and Fathmm identified 48 and 38 SNPs, respectively to be associated with cancer. While I- Mutant and MuPro assays suggested 22 SNPs to decrease protein stability. Additionally, these 22 SNPs reside within highly conserved regions of the BRCA2 protein. Domain analysis, utilizing InterPro, pinpointed 18 deleterious mutations within crucial DNA binding domains and one in the BRC repeat region.

CONCLUSION:

This study establishes a foundation for future experimental validations and the creation of breast cancer-targeted treatment approaches.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Protéine BRCA2 Limites: Female / Humans Langue: En Journal: Cell Physiol Biochem Sujet du journal: BIOQUIMICA / FARMACOLOGIA Année: 2024 Type de document: Article Pays d'affiliation: Pakistan Pays de publication: Allemagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Protéine BRCA2 Limites: Female / Humans Langue: En Journal: Cell Physiol Biochem Sujet du journal: BIOQUIMICA / FARMACOLOGIA Année: 2024 Type de document: Article Pays d'affiliation: Pakistan Pays de publication: Allemagne